These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
822 related articles for article (PubMed ID: 26142300)
1. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study. Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M; Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300 [TBL] [Abstract][Full Text] [Related]
2. Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study. Botto GL; Ricci RP; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Garutti C; Vainer L; Kozák M; Heart Rhythm; 2014 Jun; 11(6):992-1000. PubMed ID: 24418164 [TBL] [Abstract][Full Text] [Related]
3. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial. Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G; Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753 [TBL] [Abstract][Full Text] [Related]
4. Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial. Boriani G; Pieragnoli P; Botto GL; Puererfellner H; Mont L; Ziacchi M; Manolis AS; Gulizia M; Tukkie R; Landolina M; Ricciardi G; Cicconelli M; Grammatico A; Biffi M Europace; 2019 Apr; 21(4):636-644. PubMed ID: 30649270 [TBL] [Abstract][Full Text] [Related]
5. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Boriani G; Tukkie R; Manolis AS; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; de Sousa J; Botto GL; Mangoni L; Grammatico A; Padeletti L; Eur Heart J; 2014 Sep; 35(35):2352-62. PubMed ID: 24771721 [TBL] [Abstract][Full Text] [Related]
6. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality. Ousdigian KT; Borek PP; Koehler JL; Heywood JT; Ziegler PD; Wilkoff BL Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):370-6. PubMed ID: 24838004 [TBL] [Abstract][Full Text] [Related]
7. Managed ventricular pacing vs. conventional dual-chamber pacing for elective replacements: the PreFER MVP study: clinical background, rationale, and design. Quesada A; Botto G; Erdogan A; Kozak M; Lercher P; Nielsen JC; Piot O; Ricci R; Weiss C; Becker D; Wetzels G; De Roy L; Europace; 2008 Mar; 10(3):321-6. PubMed ID: 18308753 [TBL] [Abstract][Full Text] [Related]
8. The risk of atrial fibrillation during right ventricular pacing. Pastore G; Zanon F; Baracca E; Aggio S; Corbucci G; Boaretto G; Roncon L; Noventa F; Barold SS Europace; 2016 Mar; 18(3):353-8. PubMed ID: 26443444 [TBL] [Abstract][Full Text] [Related]
9. Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy. Ruwald MH; Mittal S; Ruwald AC; Aktas MK; Daubert JP; McNitt S; Al-Ahmad A; Jons C; Kutyifa V; Steinberg JS; Wang P; Moss AJ; Zareba W J Am Coll Cardiol; 2014 Sep; 64(10):971-81. PubMed ID: 25190230 [TBL] [Abstract][Full Text] [Related]
10. Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study. Chen S; Chen K; Tao Q; Zheng L; Shen F; Wu S; Fan J; Xu G; Wang L; Zhou X; Zhang S; Europace; 2014 Nov; 16(11):1595-602. PubMed ID: 24706091 [TBL] [Abstract][Full Text] [Related]
11. Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs. Sweeney MO; Ellenbogen KA; Casavant D; Betzold R; Sheldon T; Tang F; Mueller M; Lingle J; J Cardiovasc Electrophysiol; 2005 Aug; 16(8):811-7. PubMed ID: 16101620 [TBL] [Abstract][Full Text] [Related]
12. Randomized pilot study of a new atrial-based minimal ventricular pacing mode in dual-chamber implantable cardioverter-defibrillators. Sweeney MO; Shea JB; Fox V; Adler S; Nelson L; Mullen TJ; Belk P; Casavant D; Sheldon T Heart Rhythm; 2004 Jul; 1(2):160-7. PubMed ID: 15851147 [TBL] [Abstract][Full Text] [Related]
13. Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study. Russo V; Papa AA; Rago A; Ciardiello C; Nigro G Heart Rhythm; 2018 Jul; 15(7):962-968. PubMed ID: 29524476 [TBL] [Abstract][Full Text] [Related]
14. Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers. Gonzalez M; Keating RJ; Markowitz SM; Liu CF; Thomas G; Ip JE; Lerman BB; Cheung JW Heart Rhythm; 2014 Dec; 11(12):2214-21. PubMed ID: 25131667 [TBL] [Abstract][Full Text] [Related]
15. Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial. Boriani G; Manolis AS; Tukkie R; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; Gulizia M; Samoilenko IV; Wolff C; Holbrook R; Gavazza F; Padeletti L; Heart Rhythm; 2015 Jun; 12(6):1192-200. PubMed ID: 25701774 [TBL] [Abstract][Full Text] [Related]
16. Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator. Barsheshet A; Moss AJ; McNitt S; Jons C; Glikson M; Klein HU; Huang DT; Steinberg JS; Brown MW; Zareba W; Goldenberg I; Heart Rhythm; 2011 Feb; 8(2):212-8. PubMed ID: 21044897 [TBL] [Abstract][Full Text] [Related]
17. Atrial antitachycardia pacing and atrial remodeling: A substudy of the international, randomized MINERVA trial. Boriani G; Tukkie R; Biffi M; Mont L; Ricci R; Pürerfellner H; Botto GL; Manolis AS; Landolina M; Gulizia M; Hudnall JH; Mangoni L; Grammatico A; Padeletti L; Heart Rhythm; 2017 Oct; 14(10):1476-1484. PubMed ID: 28506917 [TBL] [Abstract][Full Text] [Related]
18. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study. Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033 [TBL] [Abstract][Full Text] [Related]
19. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients. Adelstein E; Saba S Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497 [TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing. Nielsen JC; Thomsen PE; Højberg S; Møller M; Riahi S; Dalsgaard D; Mortensen LS; Nielsen T; Asklund M; Friis EV; Christensen PD; Simonsen EH; Eriksen UH; Jensen GV; Svendsen JH; Toff WD; Healey JS; Andersen HR; Europace; 2012 May; 14(5):682-9. PubMed ID: 22106360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]